Inhibition of expression of interleukin-5

Details Inhibition of expression of interleukin-5 Inhibition of expression of interleukin-5

1998-05-15

2000-04-11

Brusca, John S.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

536 245, C12N 506, C07H 2100

Patent

active

060487267

ABSTRACT:
A method of inhibiting interleukin-5 expression using an antisense oligonucleotide which contains at least one non-natural internucleoside linkage.

REFERENCES:
patent: 5514788 (1996-05-01), Bennett et al.
patent: 5591623 (1997-01-01), Bennett et al.
patent: 5616488 (1997-04-01), Sullivan et al.
patent: 5681936 (1997-10-01), Nicholson
patent: 5728820 (1998-03-01), Akerblom
patent: 5744166 (1998-04-01), Illum
Antisense '97: A roundtable on the state of the industry. Nature Biotechnol. 15: 519-524, Jun. 1997.
De Mesmaeker et al. Antisense Oligonucleotides. Acc. Chem Res. 28: 366-374, Sep. 1995.
Faccioli et al. IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome. Mediators of Inflammation 5: 24-31, Jan. 1996.
Gewirtz et al. Facilitating oligonucleotide delivery: Helping antisense deliver on its promise. Proc. Natl. Acad. Sci. USA 93: 3161-3163, Apr. 1996.
Gura. Antisense has growing pains. Science 270:575-577, Oct. 1995.
Rojanasakul. Antisense oligonucleotide therapeutics: Drug delivery and targeting. Adv. Drug Delivery Reviews 18: 115-131, 1996.
Azuma et tal., "Cloning of cDna for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue", Nucleic Acids Res. 14(22):9149-58 (1986).
Agrawal et al., "Site specific functionalization of oligonucleotides for attaching two different reporter groups", Nucleic Acids Res. 18:5419-5423 (1990).
Cosstick et al., "Fluorescent labelling of tRNA and oligodeoxynucleotides using T4 RNA ligase", Nucleic Acids Res. 12:1791-1810 (1984).
Eckstein et al., "Phosphorothioates in molecular biology," TIBS 14:97-100 (1989).
Edwards, "Polarizability, Basicity and Nucleophilic Character", J. Amer. Chem. Soc. 78:1819-21 (1956).
Fidanza et al., "Introduction of Reporter Groups at Specific Sites in DNA Containing Phosphorothioate Diesters", J. Am. Chem. Soc. 111:9117-9119 (1989).
Frey et al., "Bond Order and Charge Localization in Nucleoside Phosphorothioates", Science 228:541-45 (1985).
Geary et al., "Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides", Anti-cancer Drug Des. 12:383-93 (1997).
Ginobbi et al., "Folic Acid-Polylysine Carrier Improves Efficacy of c-myc Antisense Oligodeooxynucleotides on Human Melanoma (M14) Cells", Anticancer Res. 17:29-35 (1997).
Gish et al., "DNA and RNA Sequence Determination Based on Phosphorothiaoate Chemistry", Science 240:1520-22 (1988).
Goody et al., "Thiophosphate Analogs of Nucleoside Di- and Triphosphate", J. Am. Chem. Soc. 93:6252-57 (1971).
Henry et al., "Antisense oligonucleotide inhibitors for the treatment of cancer: 2. Toxicological properties of phosphorothioate oligodeoxynucleotides", Anti-cancer Drug Des. 12:395-408 (1997).
Hodges et al., "Post-Assay" Covalent Labeling of Phosphorothioate-Containing Nucleic Acids with Multiple Fluorescent Markers, Biochem. 28:261-67 (1989).
Karim et al., "Maleimide-mediated protein conjugates of a nucleoside triphosphate gamma-S and an internucleotide phosphorothioate diester", Nucleic Acids Res. 23:2037-2040 (1995).
Sharma et al., "The NF-kB Transcription Factor in Oncogenesis", Anticancer Res. 16:589-96 (1996).
Weltman et al., "Selection of Antisense Sequences Against Human Interleukin-5 by Maximization of G+C Content", (posted Apr. 3, 1998, visited Apr. 23, 1998) <http://www.faseb.org/asbmb/asbmb98/f2657.html>.
"Hybridon Signs Research Collaboration with Leading Medical Institutions In Paris and Oslo to Develop Antisense Therapies for Asthma and Cancer" visited May 15, 1998 <http://www.hybridon.com/graphic.sub.-- ye . . . o
ews.sub.-- releases
ews96/090996.html>.

Affiliated with

Also associated with

Rating

Inhibition of expression of interleukin-5 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of expression of interleukin-5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of expression of interleukin-5 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1175701